Physician profile
Jeffrey D Hyde
NPI 1336143841
$4,213.22
in general payments reported to CMS, 2019-2025
43 companies · $525 in 2025
The $525 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $494 · 2021: $342 · 2022: $426 · 2023: $451 · 2024: $549 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,503.80 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $595.48 | 2019-2025 | |
| Amgen INC. | $409.87 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $401.30 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325.76 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $317.21 | 2019-2020 | |
| Pfizer INC. | $215.69 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $164.77 | 2023-2025 | Verquvo, Capvaxive |
| Cleerly, INC. | $162.34 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Abiomed | $135.36 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $123.56 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $119.63 | 2019-2024 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $98.57 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $84.35 | 2022-2025 | Assure Wcd |
| Chiesi USA, INC. | $76.67 | 2020-2021 | |
| Ethicon US, LLC | $74.66 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.